<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>大叔快评 | wechat-feeds</title><link>http://MzA3NzY1MjAzNg.favicon.privacyhide.com/favicon.ico</link><description>肿瘤学临床研究及制药企业研发评述</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 22 Apr 2021 23:24:00 +0800</pubDate><image><url>http://MzA3NzY1MjAzNg.favicon.privacyhide.com/favicon.ico</url><title>大叔快评 | wechat-feeds</title><link>http://MzA3NzY1MjAzNg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>武田制药出席2021博鳌亚洲论坛</title><link>https://mp.weixin.qq.com/s/_STnrAaITbamNleYTX1mBQ</link><description></description><content:encoded><![CDATA[武田制药出席2021博鳌亚洲论坛]]></content:encoded><pubDate>Thu, 22 Apr 2021 22:35:04 +0800</pubDate></item><item><title>探“泌”书局 I 一文梳理mHSPC的ADT联合治疗</title><link>https://mp.weixin.qq.com/s/4oFWEeeYOGMuke4F0OZOsA</link><description></description><content:encoded><![CDATA[探“泌”书局 I 一文梳理mHSPC的ADT联合治疗]]></content:encoded><pubDate>Thu, 22 Apr 2021 22:35:04 +0800</pubDate></item><item><title>AACR I CD19和CD20双靶点CAR-T初步结果</title><link>https://mp.weixin.qq.com/s/Wz3j2GG7A0ehQMHykEbqjw</link><description></description><content:encoded><![CDATA[AACR I CD19和CD20双靶点CAR-T初步结果]]></content:encoded><pubDate>Wed, 21 Apr 2021 16:03:11 +0800</pubDate></item><item><title>陈赛娟院士：急性淋巴细胞白血病诊断策略和发病机制研究</title><link>https://mp.weixin.qq.com/s/Cv7YjIbvHCcKD6S9hGIxgQ</link><description></description><content:encoded><![CDATA[陈赛娟院士：急性淋巴细胞白血病诊断策略和发病机制研究]]></content:encoded><pubDate>Wed, 21 Apr 2021 16:03:11 +0800</pubDate></item><item><title>孙春艳教授点评｜路在何方-多发性骨髓瘤合并COVID-19病例分享</title><link>https://mp.weixin.qq.com/s/f6meaOqrfHLTYc0-tvyetQ</link><description></description><content:encoded><![CDATA[孙春艳教授点评｜路在何方-多发性骨髓瘤合并COVID-19病例分享]]></content:encoded><pubDate>Wed, 21 Apr 2021 16:03:11 +0800</pubDate></item><item><title>ALCANZA研究亚组分析：维布妥昔单抗与医生选择方案治疗伴大细胞转化CD30阳性蕈样霉菌病疗效评估</title><link>https://mp.weixin.qq.com/s/MvSmev9AiI9DRuQche8Jaw</link><description></description><content:encoded><![CDATA[ALCANZA研究亚组分析：维布妥昔单抗与医生选择方案治疗伴大细胞转化CD30阳性蕈样霉菌病疗效评估]]></content:encoded><pubDate>Tue, 20 Apr 2021 12:54:59 +0800</pubDate></item><item><title>武田注射用维布妥昔单抗获批皮肤T细胞淋巴瘤两项新适应症</title><link>https://mp.weixin.qq.com/s/RMzzWvZxhWywEHxAE2MT3g</link><description></description><content:encoded><![CDATA[武田注射用维布妥昔单抗获批皮肤T细胞淋巴瘤两项新适应症]]></content:encoded><pubDate>Tue, 20 Apr 2021 12:54:59 +0800</pubDate></item><item><title>看报告 涨知识 I 2021年Q1全球医疗健康产业资本报告节选</title><link>https://mp.weixin.qq.com/s/HlLshiR5PXc9juULzc4n_Q</link><description></description><content:encoded><![CDATA[看报告 涨知识 I 2021年Q1全球医疗健康产业资本报告节选]]></content:encoded><pubDate>Sun, 18 Apr 2021 22:23:50 +0800</pubDate></item><item><title>世界血友病日 我们仍然在一起</title><link>https://mp.weixin.qq.com/s/mxPetWThhjtl7eQhWdXNgA</link><description></description><content:encoded><![CDATA[世界血友病日 我们仍然在一起]]></content:encoded><pubDate>Sun, 18 Apr 2021 22:23:50 +0800</pubDate></item><item><title>“唱响璀璨友生”2021世界血友病日主题活动顺利举办</title><link>https://mp.weixin.qq.com/s/XrSasca53GM5WQH48yhyfA</link><description></description><content:encoded><![CDATA[“唱响璀璨友生”2021世界血友病日主题活动顺利举办]]></content:encoded><pubDate>Sun, 18 Apr 2021 15:02:18 +0800</pubDate></item><item><title>看新闻 涨知识 I FDA批准nivloluamb联合化疗治疗胃癌一线适应症</title><link>https://mp.weixin.qq.com/s/gQ6fYlGsvgSLcNMrlgDj3g</link><description></description><content:encoded><![CDATA[看新闻 涨知识 I FDA批准nivloluamb联合化疗治疗胃癌一线适应症]]></content:encoded><pubDate>Sat, 17 Apr 2021 09:37:32 +0800</pubDate></item><item><title>武田注射用维布妥昔单抗获批皮肤T细胞淋巴瘤两项新适应症</title><link>https://mp.weixin.qq.com/s/Qh0PMyaMgyX8OjuKNrhxoQ</link><description></description><content:encoded><![CDATA[武田注射用维布妥昔单抗获批皮肤T细胞淋巴瘤两项新适应症]]></content:encoded><pubDate>Fri, 16 Apr 2021 16:50:48 +0800</pubDate></item><item><title>读报告 涨知识 I IQVIA院内销售MAT202102增长率-6.7%</title><link>https://mp.weixin.qq.com/s/THENHUloPXLjLxcob4pr-Q</link><description></description><content:encoded><![CDATA[读报告 涨知识 I IQVIA院内销售MAT202102增长率-6.7%]]></content:encoded><pubDate>Thu, 15 Apr 2021 23:08:32 +0800</pubDate></item><item><title>PK指导重型血友病A儿童预防治疗-北京儿童医院单中心经验</title><link>https://mp.weixin.qq.com/s/8YIwSxfay3IRqpetrHIVGg</link><description></description><content:encoded><![CDATA[PK指导重型血友病A儿童预防治疗-北京儿童医院单中心经验]]></content:encoded><pubDate>Thu, 15 Apr 2021 23:08:32 +0800</pubDate></item><item><title>读报告 涨知识 I如何启动Medical Affairs的科学“核动力”</title><link>https://mp.weixin.qq.com/s/uRtVgt3YLoQCzXrTbbxMkg</link><description></description><content:encoded><![CDATA[读报告 涨知识 I如何启动Medical Affairs的科学“核动力”]]></content:encoded><pubDate>Wed, 14 Apr 2021 22:46:20 +0800</pubDate></item><item><title>【AACR2021】新一代ALK抑制剂NUV-655</title><link>https://mp.weixin.qq.com/s/bm9eoQykGC5YEbcPyrKWFw</link><description></description><content:encoded><![CDATA[【AACR2021】新一代ALK抑制剂NUV-655]]></content:encoded><pubDate>Wed, 14 Apr 2021 22:46:20 +0800</pubDate></item><item><title>MM课堂 | 姜华教授：2020 ASH新诊断多发性骨髓瘤治疗策略与进展</title><link>https://mp.weixin.qq.com/s/p5UTllRHUPyBFuVbkWm7rg</link><description></description><content:encoded><![CDATA[MM课堂 | 姜华教授：2020 ASH新诊断多发性骨髓瘤治疗策略与进展]]></content:encoded><pubDate>Wed, 14 Apr 2021 22:46:20 +0800</pubDate></item><item><title>【AACR2021】新一代ROS1抑制剂NUV-520</title><link>https://mp.weixin.qq.com/s/tnia15FPZX2gH2OLBdO3ww</link><description></description><content:encoded><![CDATA[【AACR2021】新一代ROS1抑制剂NUV-520]]></content:encoded><pubDate>Wed, 14 Apr 2021 22:46:20 +0800</pubDate></item><item><title>看报告 涨知识 I Pharma R&amp;D Annual Review 2021节选</title><link>https://mp.weixin.qq.com/s/0YC4f-Xko8cahdxOht0w5g</link><description></description><content:encoded><![CDATA[看报告 涨知识 I Pharma R&D Annual Review 2021节选]]></content:encoded><pubDate>Mon, 12 Apr 2021 22:55:48 +0800</pubDate></item><item><title>破除内卷，向外突围|2021CMAC参会杂感</title><link>https://mp.weixin.qq.com/s/r7aNOmAlhlwohwS3bT3_Qw</link><description></description><content:encoded><![CDATA[破除内卷，向外突围|2021CMAC参会杂感]]></content:encoded><pubDate>Mon, 12 Apr 2021 22:55:48 +0800</pubDate></item></channel></rss>